194 related articles for article (PubMed ID: 28235801)
1. The scaffolding protein NHERF1 regulates the stability and activity of the tyrosine kinase HER2.
Jeong J; VanHouten JN; Kim W; Dann P; Sullivan C; Choi J; Sneddon WB; Friedman PA; Wysolmerski JJ
J Biol Chem; 2017 Apr; 292(16):6555-6568. PubMed ID: 28235801
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ezrin causes PKCα-mediated internalization of erbb2/HER2 tyrosine kinase in breast cancer cells.
Jeong J; Choi J; Kim W; Dann P; Takyar F; Gefter JV; Friedman PA; Wysolmerski JJ
J Biol Chem; 2019 Jan; 294(3):887-901. PubMed ID: 30463939
[TBL] [Abstract][Full Text] [Related]
3. PMCA2 regulates HER2 protein kinase localization and signaling and promotes HER2-mediated breast cancer.
Jeong J; VanHouten JN; Dann P; Kim W; Sullivan C; Yu H; Liotta L; Espina V; Stern DF; Friedman PA; Wysolmerski JJ
Proc Natl Acad Sci U S A; 2016 Jan; 113(3):E282-90. PubMed ID: 26729871
[TBL] [Abstract][Full Text] [Related]
4. NHERF1 Is Required for Localization of PMCA2 and Suppression of Early Involution in the Female Lactating Mammary Gland.
Jeong J; Kim W; Hens J; Dann P; Schedin P; Friedman PA; Wysolmerski JJ
Endocrinology; 2019 Aug; 160(8):1797-1810. PubMed ID: 31087002
[TBL] [Abstract][Full Text] [Related]
5. MAL2 mediates the formation of stable HER2 signaling complexes within lipid raft-rich membrane protrusions in breast cancer cells.
Jeong J; Shin JH; Li W; Hong JY; Lim J; Hwang JY; Chung JJ; Yan Q; Liu Y; Choi J; Wysolmerski J
Cell Rep; 2021 Dec; 37(13):110160. PubMed ID: 34965434
[TBL] [Abstract][Full Text] [Related]
6. HER2 signaling regulates HER2 localization and membrane retention.
Jeong J; Kim W; Kim LK; VanHouten J; Wysolmerski JJ
PLoS One; 2017; 12(4):e0174849. PubMed ID: 28369073
[TBL] [Abstract][Full Text] [Related]
7. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
Pan Y; Weinman EJ; Dai JL
Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691
[TBL] [Abstract][Full Text] [Related]
8. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.
Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J
Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983
[TBL] [Abstract][Full Text] [Related]
9. The calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin.
Peters AA; Milevskiy MJ; Lee WC; Curry MC; Smart CE; Saunus JM; Reid L; da Silva L; Marcial DL; Dray E; Brown MA; Lakhani SR; Roberts-Thomson SJ; Monteith GR
Sci Rep; 2016 May; 6():25505. PubMed ID: 27148852
[TBL] [Abstract][Full Text] [Related]
10. The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.
Cardone RA; Bellizzi A; Busco G; Weinman EJ; Dell'Aquila ME; Casavola V; Azzariti A; Mangia A; Paradiso A; Reshkin SJ
Mol Biol Cell; 2007 May; 18(5):1768-80. PubMed ID: 17332506
[TBL] [Abstract][Full Text] [Related]
11. A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression.
Yang X; Du G; Yu Z; Si Y; Martin TA; He J; Cheng S; Jiang WG
Anticancer Res; 2017 Jan; 37(1):67-73. PubMed ID: 28011475
[TBL] [Abstract][Full Text] [Related]
12. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer.
Du G; Gu Y; Hao C; Yuan Z; He J; Jiang WG; Cheng S
Oncotarget; 2016 May; 7(20):29440-53. PubMed ID: 27097111
[TBL] [Abstract][Full Text] [Related]
13. Dynamic Na+-H+ exchanger regulatory factor-1 association and dissociation regulate parathyroid hormone receptor trafficking at membrane microdomains.
Ardura JA; Wang B; Watkins SC; Vilardaga JP; Friedman PA
J Biol Chem; 2011 Oct; 286(40):35020-9. PubMed ID: 21832055
[TBL] [Abstract][Full Text] [Related]
14. HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer.
Schulz R; Streller F; Scheel AH; Rüschoff J; Reinert MC; Dobbelstein M; Marchenko ND; Moll UM
Cell Death Dis; 2014 Jan; 5(1):e980. PubMed ID: 24384723
[TBL] [Abstract][Full Text] [Related]
15. Apical scaffolding protein NHERF2 modulates the localization of alternatively spliced plasma membrane Ca2+ pump 2B variants in polarized epithelial cells.
Padányi R; Xiong Y; Antalffy G; Lór K; Pászty K; Strehler EE; Enyedi A
J Biol Chem; 2010 Oct; 285(41):31704-12. PubMed ID: 20663896
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of NHERF1 S279 and S301 differentially regulates breast cancer cell phenotype and metastatic organotropism.
Greco MR; Bon E; Rubino R; Guerra L; Bernabe-Garcia M; Cannone S; Cayuela ML; Ciaccia L; Marionneau-Lambot S; Oullier T; Fromont G; Guibon R; Roger S; Reshkin SJ; Cardone RA
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):26-37. PubMed ID: 30326259
[TBL] [Abstract][Full Text] [Related]
17. Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling.
Wheeler DS; Barrick SR; Grubisha MJ; Brufsky AM; Friedman PA; Romero G
Oncogene; 2011 Jan; 30(1):32-42. PubMed ID: 20802536
[TBL] [Abstract][Full Text] [Related]
18. PMCA2 regulates apoptosis during mammary gland involution and predicts outcome in breast cancer.
VanHouten J; Sullivan C; Bazinet C; Ryoo T; Camp R; Rimm DL; Chung G; Wysolmerski J
Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11405-10. PubMed ID: 20534448
[TBL] [Abstract][Full Text] [Related]
19. Nuclear NHERF1 expression as a prognostic marker in breast cancer.
Paradiso A; Scarpi E; Malfettone A; Addati T; Giotta F; Simone G; Amadori D; Mangia A
Cell Death Dis; 2013 Nov; 4(11):e904. PubMed ID: 24201803
[TBL] [Abstract][Full Text] [Related]
20. NHERF1: molecular brake on the PI3K pathway in breast cancer.
Georgescu MM
Breast Cancer Res; 2008; 10(2):106. PubMed ID: 18430260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
